Clinical Trial: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439848) titled 'Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis' on June 28, 2023.

Brief Summary: This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.

Study Start Date: Dec. 25, 2023

Study Type: INTERVENTIONAL

Condition: Acute Respiratory Distress Syndrome

Intervention: OTHER: Control (NaCl 0.9%)

Standard of Care (SoC) + IV placebo (NaCl...